Intrinsic Value of S&P & Nasdaq Contact Us

U.S. Physical Therapy, Inc. USPH NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
59/100
2/7 Pass
SharesGrow Intrinsic Value
$50.65
-34.3%
Analyst Price Target
$102.00
+32.2%

U.S. Physical Therapy, Inc. (USPH) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $77.13. It has a SharesGrow Score of 59/100, indicating a above average investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of USPH = $50.65 (-34.3% from the current price, the stock appears overvalued). Analyst consensus target is USPH = $102 (+32.2% upside).

Valuation: USPH trades at a trailing Price-to-Earnings (P/E) of 75.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 5.03.

Financials: revenue is $781M, +13.8%/yr average growth. Net income is $15M, growing at -9.7%/yr. Net profit margin is 1.9% (thin). Gross margin is 20.1% (-0.2 pp trend).

Balance sheet: total debt is $426M against $476M equity (Debt-to-Equity (D/E) ratio 0.89, moderate). Current ratio is 1.01 (adequate). Debt-to-assets is 35.4%. Total assets: $1.2B.

Analyst outlook: 9 / 12 analysts rate USPH as buy (75%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 36/100 (Fail), Growth 48/100 (Partial), Past 100/100 (Pass), Health 67/100 (Partial), Moat 45/100 (Partial), Future 85/100 (Pass), Income 30/100 (Fail).

$102.00
▲ 32.24% Upside
Average Price Target
The 12-month price target for U.S. Physical Therapy, Inc. is $102.00.

USPH SharesGrow Score Overview

59/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 36/100
Valuation — P/E, PEG, Forward PEG
GROWTH 48/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 45/100
Gross margin is + market cap
FUTURE 85/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — USPH

VALUE Fail
36/100
USPH trades at a trailing Price-to-Earnings (P/E) of 75.9 (S&P 500 average ~25). Forward PEG 5.03 — overvalued. Analyst consensus target is $102, implying +32.2% from the current price $77. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
48/100
USPH: +13.8%/yr revenue is, -9.7%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
USPH: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet USPH: Debt-to-Equity (D/E) ratio 0.89 (moderate), Current ratio is 1.01 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
45/100
USPH: Gross margin is 20.1% (-0.2 pp trend), $1B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 45/100. ≥ 70 = Pass.
View details →
FUTURE Pass
85/100
Analyst outlook: 9 / 12 analysts rate USPH as buy (75%). Analyst consensus target is $102 (+32.2% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
30/100
USPH: Net profit margin is 1.9%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range62.77-93.5
Volume115.16K
Avg Volume (30D)193.12K
Market Cap$1.17B
Beta (1Y)1.35
Dividend Yield$1.8100
Share Statistics
EPS (TTM)1.42
Shares Outstanding$15.18M
IPO Date1992-05-29
Employees4,034
CEOChristopher J. Reading
Financial Highlights & Ratios
Revenue (TTM)$780.99M
Gross Profit$157.34M
EBITDA$109.66M
Net Income$15.06M
Operating Income$80.43M
Total Cash$35.57M
Total Debt$425.74M
Net Debt$390.17M
Total Assets$1.2B
Price / Earnings (P/E)54.3
Price / Sales (P/S)1.5
Analyst Forecast
1Y Price Target$102.00
Target High$102.00
Target Low$102.00
Upside+32.2%
Rating ConsensusBuy
Analysts Covering12
Buy 75% Hold 25% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS90337L1089

Price Chart

USPH
U.S. Physical Therapy, Inc.  ·  NYSE
Healthcare • Medical - Care Facilities
62.77 52WK RANGE 93.50
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message